Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia

Journal of Pediatrics

Volumn 141, Issue 1, 2002, Pages 125-128

  Jaeger, Beate Roxane ^a,b   Tsobanelis, Theoharis ^a,b   Bengel, Frank ^a,b   Schwaiger, Markus ^a,b   Seidel, Dietrich ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Dialysezentrum Kuratorium Für Heimdialyse KfH Rödelheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NITROGEN 13; SIMVASTATIN; STATIN; VITAMIN D;

ADULT; APHERESIS; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFICACY; DRUG SAFETY; ELECTRON BEAM; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART MUSCLE BLOOD FLOW; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; STRESS; XANTHOMA;

EID: 0036065554     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.124384     Document Type: Article

References (12)

1. Familial hypercholesterolemia
2. Improved survival of patients with homozygous familial hypercholesterolemia treated with plasma exchange
3. Low-density lipoprotein plasmapheresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolemia
4. The HELP-LDL-apheresis multicenter study, an angiographically assessed trial into the role of LDL-apheresis in the secondary prevention of coronary heart disease, I: Evaluation of safety and cholesterol-lowering effects during the first 12 months
5. The HELP-LDL-apheresis multicenter study, an angiographically assessed trial into the role of LDL-apheresis in the secondary prevention of coronary heart disease, II: Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease
6. Quantification of coronary artery calcium using ultrafast computed tomography
7. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET
8. Quantification of regional myocardial perfusion by PET: Rationale and first clinical results
9. Detection and quantification of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia
10. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis
11. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation
12. Evidence for maximal treatment of atherosclerosis: Drastic reduction of cholesterol and fibrinogen restores vascular homeostasis